New tetrazoloquinolinyl methoxyphenyl-4-thiazolidinones: synthesis and antihyperglycemic evaluation

New tetrazoloquinolinyl methoxyphenyl-4-thiazolidinones: synthesis and antihyperglycemic evaluation Electronic supplementary material The online version of this article (doi:10.1007/s11164-016-2686-5) contains supplementary material, which is available to authorized users. & Ramrao A. Mane manera2011@gmail.com Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, MS 431004, India Biochemistry Division, CSIR-Central Drug Research Institute, Lucknow 226031, India 123 1108 A. R. Deshmukh et al. Keywords Diabetes mellitus  Antihyperglycemic agents Tetrazolo[1,5-a]quinoline  4-Thiazolidinones Introduction Diabetes mellitus is a major metabolic disorder, being considered to be one of the greatest health catastrophes in the world. Approximately 415 million people are affected by diabetes, and this number is predicted to increase to 642 million by 2040 [1]. Non-insulin-dependent diabetes mellitus (NIDDM/type 2) is the most predom- inant form of diabetes; it is a complex metabolic disorder with multiple heterogeneous etiologies, characterized by insulin resistance and impaired insulin secretion. These metabolic disorders cause hyperglycemia, which is significantly responsible for diabetic complications [2–4]. Microangiopathic complications of untreated or inadequately treated diabetes include neuropathy, nephropathy, retinopathy, obesity, dyslipidemia, hypertension, and other cardiovascular diseases. These are believed to be triggered by excessive protein glycation due to the higher level of circulating glucose, i.e., hyperglycemia [5–9]. Hence, in recent years, several researchers have focused their attention on development http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Research on Chemical Intermediates Springer Journals

New tetrazoloquinolinyl methoxyphenyl-4-thiazolidinones: synthesis and antihyperglycemic evaluation

Loading next page...
 
/lp/springer_journal/new-tetrazoloquinolinyl-methoxyphenyl-4-thiazolidinones-synthesis-and-Qd2D5goaJE
Publisher
Springer Netherlands
Copyright
Copyright © 2016 by Springer Science+Business Media Dordrecht
Subject
Chemistry; Catalysis; Physical Chemistry; Inorganic Chemistry
ISSN
0922-6168
eISSN
1568-5675
D.O.I.
10.1007/s11164-016-2686-5
Publisher site
See Article on Publisher Site

Abstract

Electronic supplementary material The online version of this article (doi:10.1007/s11164-016-2686-5) contains supplementary material, which is available to authorized users. & Ramrao A. Mane manera2011@gmail.com Department of Chemistry, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, MS 431004, India Biochemistry Division, CSIR-Central Drug Research Institute, Lucknow 226031, India 123 1108 A. R. Deshmukh et al. Keywords Diabetes mellitus  Antihyperglycemic agents Tetrazolo[1,5-a]quinoline  4-Thiazolidinones Introduction Diabetes mellitus is a major metabolic disorder, being considered to be one of the greatest health catastrophes in the world. Approximately 415 million people are affected by diabetes, and this number is predicted to increase to 642 million by 2040 [1]. Non-insulin-dependent diabetes mellitus (NIDDM/type 2) is the most predom- inant form of diabetes; it is a complex metabolic disorder with multiple heterogeneous etiologies, characterized by insulin resistance and impaired insulin secretion. These metabolic disorders cause hyperglycemia, which is significantly responsible for diabetic complications [2–4]. Microangiopathic complications of untreated or inadequately treated diabetes include neuropathy, nephropathy, retinopathy, obesity, dyslipidemia, hypertension, and other cardiovascular diseases. These are believed to be triggered by excessive protein glycation due to the higher level of circulating glucose, i.e., hyperglycemia [5–9]. Hence, in recent years, several researchers have focused their attention on development

Journal

Research on Chemical IntermediatesSpringer Journals

Published: Aug 10, 2016

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off